The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care
Abstract
Blood cultures are limited for diagnosing invasive candidiasis by poor sensitivity and slow turn-around time. New diagnostics are needed to complement cultures, in particular to identify the "missing 50%" of patients who are blood culture-negative. Mannan/anti-mannan immunoglobulin G, β-D-glucan (BDG) and polymerase chain reaction (PCR) assays can diagnose candidemia before blood cultures and show promising sensitivity/specificity, but they are not widely investigated in blood culture-negative, deep-seated candidiasis. In a recent study, BDG and PCR were superior to blood cultures in deep-seated candidiasis, suggesting they may identify currently undiagnosed patients and expand our understanding of disease spectrum. Positive predictive values of nonculture tests are limited by the low prevalence of invasive candidiasis, which mandates that results be interpreted judiciously. When used as biomarkers that assess a patient's risk of having invasive candidiasis, tests will facilitate preemptive antifungal strategies. Because negative predictive values are excellent, tests will also be useful for ruling out invasive candidiasis and discontinuing unnecessary antifungal therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blood cultures, however, are positive in only 21–71% of patients later proven by autopsy to have IC.16”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [16]
In the citing paper
“In concert, this data has led to the conclusion that the sensitivity for blood cultures for invasive candidiasis is only 50%.16”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [16]
In the citing paper
“However, blood cultures cannot be relied upon in all cases of IC given approximately one-third of patients with IC are categorized as having deep-seated infection without candidemia.16”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [16]
In the citing paper
“Previous studies of autopsy-proven invasive candidiasis suggest that blood cultures are positive in 21%-71% of cases [9], which suggests that the estimated burden of invasive candidiasis would be even higher, although further evaluation of the relative burden of candidemia in overall invasive candidiasis is needed.”
From Burden of Candidemia in the United States, 2017 (2020) · cites this paper as [9]
In the citing paper
“StC events could have been missed because of missed screening opportunities, the insensitivity of culture (9), treating clinical laboratories that might not routinely distinguish C. auris from other Candida species for nonsterile specimen types (10), and the fact that US C. auris data from 2024 are not finalized, meaning some patients might not have had sufficient lead time for clinical cases to”
From Progression from Candida auris Colonization Screening to Clinical Case Status, United States, 2016–2023 (2025) · cites this paper as [9]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758
Self-citation-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
Leroy, O., Gangneux, J.-P., Montravers, P., Mira, J.-P., Gouin, F., Sollet, J.-P., Carlet, J., Reynes, J., Rosenheim, M., Regnier, B., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819efac0 · Cited by 535
Hepatic Candidiasis in Cancer Patients: The Evolving Picture of the Syndrome
THALER, M., PASTAKIA, B., SHAWKER, T. H., O'LEARY, T., & PIZZO, P. A. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-88 · Cited by 395
PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
Avni, T., Leibovici, L., & Paul, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01602-10 · Cited by 389
Ostrosky-Zeichner, L., Sable, C., Sobel, J., Alexander, B. D., Donowitz, G., Kan, V., Kauffman, C. A., Kett, D., Larsen, R. A., Morrison, V., et al. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0270-z · Cited by 369
Mikulska, M., Calandra, T., Sanguinetti, M., Poulain, D., Viscoli, C., & the Third European Conference on Infections in Leukemia Group (2010) · Critical Care · doi:10.1186/cc9365 · Cited by 319
Research works printed but not linked: 1
- Nguyen MH Clancy CJ . Washington, DC: American Society for Microbiology; 2012. Intra-abdominal candidiasis (IAC) Is under-recognized, but is the most common yype of invasive candidiasis (IC) and results in poor outcomes [abstract M1685]; p. 164. Program and abstracts of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco.
Cited by
Items 101–200 of 688
Diagnostic Performance of T2Candida Among ICU Patients With Risk Factors for Invasive Candidiasis
Arendrup, M. C., Andersen, J. S., Holten, M., Krarup, K. B., Reiter, N., Schierbeck, J., & Helleberg, M. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz136 · Cited by 55
“Autopsy studies have suggested a sensitivity between 21% and 71%, which is highest if large-volume BCs (60 mL) are obtained daily and additional sets are obtained during febrile episodes [10].”
BackgroundMolecular diagnostic methods for invasive fungal disease: the horizon draws nearer?
Halliday, C. L., Kidd, S. E., Sorrell, T. C., & Chen, S. C.-A. (2015) · Pathology · doi:10.1097/pat.0000000000000234 · Cited by 55
“right © Royal College of pathologists of Australasia the diagnosis of IC,(24,25) and may provide justification for stopping antifungal therapy.(22) Whether PCR assays to detect IC are superior to traditional culture-based tests is under ongoing discussion.”
BackgroundThe Evolving Landscape of Fungal Diagnostics, Current and Emerging Microbiological Approaches
Weiss, Z., Leon, A., & Koo, S. (2021) · Journal of Fungi · doi:10.3390/jof7020127 · Cited by 57
Rautemaa‐Richardson, R., Rautemaa, V., Al-Wathiqi, F., Moore, C. B., Craig, L., Felton, T., & Muldoon, E. G. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky360 · Cited by 53
Diagnosis of Invasive Candidiasis: From Gold Standard Methods to Promising Leading-edge Technologies
Pitarch, A., Nombela, C., & Gil, C. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666181025093146 · Cited by 56
“glabrata, and another 24-48 hours for subsequent species-specific identification using conventional methods, such as Vitek 2 YST ID card (bioMérieuxe), AuxaColor 2 (Bio-Rad Laboratories), or CHROMagar Candida (CHROMagar), among others [16, 56-58].”
BackgroundMethodInfluentialChoosing the Right Antifungal Agent in ICU Patients
Chatelon, J., Cortegiani, A., Hammad, E., Cassir, N., & Léone, M. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01115-0 · Cited by 55
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 58
Parslow, B. Y., & Thornton, C. R. (2022) · Microorganisms · doi:10.3390/microorganisms10061208 · Cited by 57
“The term invasive candidiasis is used to describe two distinct disease entities: candidemia bloodstream infection (BSI) and deep-seated tissue candidiasis (Figure 1), which may occur independently or concomitantly [9].”
BackgroundInfluentialPooled analysis of T2 Candida for rapid diagnosis of candidiasis
Tang, D., Chen, X., Zhu, C.-G., Li, Z., Xia, Y., & Guo, X. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4419-z · Cited by 54
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
Thompson, G. R., Boulware, D. R., Bahr, N. C., Clancy, C. J., Harrison, T. S., Kauffman, C. A., Le, T. P., Miceli, M. H., Mylonakis, E. E., Nguyen, M. H., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac112 · Cited by 52
“Limitations of culture techniques have spurred development of culture-independent diagnostic tests for invasive candidiasis, although uncertainty about test performance, costs, and utility remains [33].”
BackgroundSelf-citationT2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications
Zacharioudakis, I. M., Zervou, F. N., & Mylonakis, E. E. (2018) · Journal of Fungi · doi:10.3390/jof4020045 · Cited by 50
“Based on available evidence, primary candidemia can result in secondary deep-seated candidiasis in up to 50% of cases due to hematogenous seeding [5,6].”
BackgroundA 5-Year Review of Invasive Fungal Infection at an Academic Medical Center
Li, Y., Gao, Y., Niu, X., Wu, Y., Du, Y., Yang, Y., Qi, R., Chen, H., Gao, X., Song, B., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.553648 · Cited by 50
Camargo, J. F., Ahmed, A. A., Lindner, M. S., Morris, M. I., Anjan, S., Anderson, A. D., Prado, C. E., Dalai, S. C., Martínez, O., & Komanduri, K. V. (2019) · F1000Research · doi:10.12688/f1000research.19766.3 · Cited by 48
on behalf of the COMIC Study Group (Collaborative Group on Mycosis), Agnelli, C., Valerio, M., Bouza, E., Vena, A., Guinea, J., Martínez‐Jiménez, M. D. C., Marcos-Zambrano, L. J., Escribano, P., & Muñóz, P. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03477-3 · Cited by 51
Poissy, J., Sendid, B., Damiens, S., Ishibashi, K. I., François, N., Kauv, M., Favory, R., Mathieu, D., & Poulain, D. (2014) · Critical Care · doi:10.1186/cc13953 · Cited by 50
Invasive candidiasis: from mycobiome to infection, therapy, and prevention
Lagunes, L., & Rello, J. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2658-0 · Cited by 56
“However, the sensitivity of blood cultures is nowhere near optimal, ranging between 21 and 71 % in autopsy studies [25].”
BackgroundAn overview of using fungal DNA for the diagnosis of invasive mycoses
White, P. L., Alanio, A., Brown, L., Cruciani, M., Hagen, F., Gorton, R., Lackner, M., Millon, L., Morton, C. O., Rautemaa‐Richardson, R., et al. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2037423 · Cited by 48
“reflect infection in the absence of culture rather than PCR false positivity [14,23].”
BackgroundAffinity molecular assay for detecting Candida albicans using chitin affinity and RPA-CRISPR/Cas12a
Shen, S., Wang, W., Ma, Y., Wang, S., Zhang, S., Cai, X.-F., Chen, L., Zhang, J., Li, Y., Wu, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53693-5 · Cited by 50
“However, BDG ’ s speci fi city was 73%, possibly in fl uenced by a high-risk control group largely consisting of patients with mucosal candidiasis or Candida colonization 44 .”
Up to date epidemiology, diagnosis and management of invasive fungal infections
Oren, I., & Paul, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12642 · Cited by 115
Diagnosis of bacteraemia and growth times
Ruiz‐Giardín, J. M., Martin-Diaz, R. M., Aroca, J. J., García-Arata, I., Martín, J. S., & Buitrago, M. S.-S. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.10.008 · Cited by 51
Mamtani, S. S., Aljanabi, N. M., Rauniyar, R. P. G., Acharya, A., & Malik, B. H. (2020) · Cureus · doi:10.7759/cureus.6695 · Cited by 58
Serious fungal infections in Canada
Dufresne, S. F., Cole, D. C., Denning, D. W., & Sheppard, D. C. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2922-y · Cited by 50
“Deep-seated Candida infections such as peritonitis and endophthalmitis are accompanied by positive blood cultures in, at most, 50% of cases [15].”
BackgroundBartoletti, M., Rinaldi, M., Pasquini, Z. A. I., Scudeller, L., Piano, S. S., Giacobbe, D. R., Maraolo, A. E., Bussini, L., Puente, F. D., Incicco, S., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.04.030 · Cited by 43
How to Identify Invasive Candidemia in ICU—A Narrative Review
Alves, J., Alonso-Tarrés, C., & Rello, J. (2022) · Antibiotics · doi:10.3390/antibiotics11121804 · Cited by 48
Prüller, F., Wagner, J., Raggam, R. B., Hoenigl, M., Kessler, H. H., Truschnig‐Wilders, M., & Krause, R. (2014) · Medical Mycology · doi:10.1093/mmy/myu023 · Cited by 42
“Determination of BDG may therefore become a valuable diagnostic tool for patients with suspected invasive fungal infection [5,22–25].”
BackgroundWhite, S., Schmidt, R. L., Walker, B. S., & Hanson, K. E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009833.pub2 · Cited by 72
An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2013) · Infection · doi:10.1007/s15010-013-0558-0 · Cited by 49
“In conclusion, earlier markers of fungal infection are needed in order to improve diagnosis of IC [14].”
BackgroundInfluentialApplication of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
Méry, A., Sendid, B., François, N., Cornu, M., Poissy, J., Guérardel, Y., & Poulain, D. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01655-16 · Cited by 45
“Difficulties in the biological detection of IFIs are related to the low yield of culture-based methods (8); blood cultures are positive in only 50% of episodes of IC and in anecdotic cases of IA.”
BackgroundT2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study
Muñóz, P., Vena, A., Machado, M., Martínez‐Jiménez, M. D. C., Gioia, F., Gómez, E., Origüen, J., Orellana, M. Á., López‐Medrano, F., Pérez-Granda, M. J., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky048 · Cited by 43
Lagunes, L., Rey-Perez, A., Martín-Gómez, M. T., Vena, A., de Egea, V., Muñóz, P., Bouza, E., Díaz‐Martín, A., Palacios-García, I., Garnacho‐Montero, J., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2775-9 · Cited by 46
Molecular Diagnostics for Invasive Fungal Diseases: Current and Future Approaches
Pham, D., Sivalingam, V., Tang, H. M., Montgomery, J. M., Chen, S. C. ‐., & Halliday, C. L. (2024) · Journal of Fungi · doi:10.3390/jof10070447 · Cited by 58
“However, the sensitivity of PCR on whole blood for non-candidaemic deep-seated candidiasis is decreased compared to candidaemic patients [64,65].”
Clancy, C. J., & Nguyen, M. H. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.919853 · Cited by 42
“Non-culture diagnostics such as b-Dglucan and mannan/anti-mannan antibody assays are directed against constituents of Candida cells rather than viable organisms [3].”
BackgroundInfluentialSelf-citationEpelbaum, O., Marinelli, T. M., Haydour, Q., Pennington, K. M., Evans, S. E., Carmona, E. M., Husain, S., Knox, K. S., Jarrett, B. J., Azoulay, É., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202410-2045st · Cited by 50
“Early diagnosis of IC to allow prompt initiation of targeted antifungal therapy is challenging because blood culture, the standard-of-care diagnostic test, has a sensitivity of less than 50%, with results delayed for up to 3 – 4 days (44, 78).”
Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections
Cornu, M., Goudjil, S., Kongolo, G., Leke, A., Poulain, D., Chouaki, T., & Sendid, B. (2017) · Medical Mycology · doi:10.1093/mmy/myx021 · Cited by 44
Recognition and diagnosis of invasive fungal infections in neonates
Calley, J. L., & Warris, A. (2017) · Journal of Infection · doi:10.1016/s0163-4453(17)30200-1 · Cited by 45
Challenges in the Diagnosis of Invasive Fungal Infections in Immunocompromised Hosts
Antinori, S., Corbellino, M., & Parravicini, C. (2018) · Current Fungal Infection Reports · doi:10.1007/s12281-018-0306-0 · Cited by 43
“In the diagnosis of invasive candidiasis (IC), the diagnostic sensitivity of blood cultures (that are considered the gold standard) is estimated to be less than 50% [32, 33] .”
BackgroundAntifungal stewardship: developments in the field
Urbancic, K. F., Thursky, K., Kong, D. C. M., Johnson, P. D. R., & Slavin, M. A. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000497 · Cited by 41
Cohen, J. F., Ouziel, A., Matczak, S., Brice, J., Spijker, R., Lortholary, O., Bougnoux, M., & Toubiana, J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.09.010 · Cited by 43
“False-positive BDG results could be explained by cellulose-containing membranes 258 used in hemodialysis, surgical glucan-containing gauzes, administration of human blood products such as 259 albumin and intravenous immunoglobulins, treatment with certain antibiotics such as piperacillin260 tazobactam, and glucan-cont…”
BackgroundMethodYu, J. B., Diaz, J. D., Goldstein, S. C., Patel, R. D., Varela, J. C., Reyenga, C. A., Smith, M. A., Smith, T., Balls, J. W., Ahmad, S., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.02.025 · Cited by 39
Wang, F., Ge, D., Wang, L., Li, N., Chen, H., Zhang, Z., Zhu, W., Wang, S., & Liang, W. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114428 · Cited by 44
Satała, D., Gonzalez‐Gonzalez, M., Smolarz, M., Surowiec, M., Kulig, K., Wronowska, E., Zawrotniak, M., Kozik, A., Rąpała‐Kozik, M., & Karkowska‐Kuleta, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.765942 · Cited by 43
β-d-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis
Martín‐Mazuelos, E., Loza, A., Castro, C., Guerrero, D. M., Zakariya, I., Saavedra, P., Ruiz‐Santana, S., Marín, E., & León, C. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3922-y · Cited by 41
Aitken, S. L., Beyda, N. D., Shah, D. N., Palmer, H. R., Lasco, T. M., Koo, H. L., & Garey, K. W. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014529928 · Cited by 38
“These diagnostics may be additionally divided into tests that identify Candida species directly from whole blood (preculture methodologies)(11-13) or after identification of yeast from the Gram strain (postculture methodologies).(9) As these rapid diagnostic tests will likely supplement, rather than replace, tradition…”
BackgroundMethodBegerow, D., Kemler, M., Feige, A., & Yurkov, A. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-61575-2_7 · Cited by 39
The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective
Ordaya, E. E., Clement, J., & Vergidis, P. I. (2023) · Mycopathologia · doi:10.1007/s11046-023-00759-5 · Cited by 44
“Candida species can cause a wide range of infections, from localized mucosal disease (e.g., vulvovaginal candidiasis) to deep-seated invasive infection and candidemia [2, 4].”
BackgroundBiofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options
Amann, V., Kissmann, A., Firacative, C., & Rosenau, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040460 · Cited by 48
“Faster, non-culture methods for identifying Candida infections include mannan and anti-mannan antibody detection [30,242,245], β -D-glucan (BDG) detection [230], C. albicans germ tube antibody (CAGTA) detection [246], PCR detection of Candida DNA [247] and the T2 magnetic resonance (T2MR) Candida…”
Bloodstream infections in internal medicine
Bono, V. D., & Giacobbe, D. R. (2016) · Virulence · doi:10.1080/21505594.2016.1140296 · Cited by 42
White, S., Walker, B. S., Hanson, K. E., & Schmidt, R. L. (2018) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqy135 · Cited by 39
Identification of Candida Species from Clinical Samples in a Honduran Tertiary Hospital
Montes, K., Ortíz, B., Galindo, C., Figueroa, I., Braham, S., & Fontecha, G. A. (2019) · Pathogens · doi:10.3390/pathogens8040237 · Cited by 43
“Moreover, they have limited sensitivity and the interpretation of the results can be moderately subjective [16].”
Walker, B. S., Powers‐Fletcher, M. V., Schmidt, R. L., & Hanson, K. E. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02971-15 · Cited by 40
“Blood culture has limited sensitivity for diagnosing invasive candidiasis, failing to detect as many as 50% of infections (39).”
BackgroundCandida auris from colonisation to candidemia: A four‐year study
Bayona, J. V. M., Tormo, N., García, C. S., Serrano, M. D. R. G., & Cardona, C. G. (2023) · Mycoses · doi:10.1111/myc.13626 · Cited by 39
Enhancing Molecular Approaches for Diagnosis of Fungal Infections
Zhang, S. X. (2013) · Future Microbiology · doi:10.2217/fmb.13.120 · Cited by 35
Pieralli, F., Corbo, L., Torrigiani, A., Mannini, D., Antonielli, E., Mancini, A., Corradi, F., Arena, F., Pignone, A. M., Morettini, A., et al. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1627-7 · Cited by 36
O’Leary, R., Einav, S., Léone, M., Madách, K., Martin, C., & Martín‐Loeches, I. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.11.020 · Cited by 36
Candida Empyema Thoracis at Two Academic Medical Centers: New Insights Into Treatment and Outcomes
Senger, S. S., Thompson, G. R., Samanta, P., Ahrens, J., Clancy, C. J., & Nguyen, M. H. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa656 · Cited by 37
“The prevalence of candidemia may have been understated by delayed collection of blood cultures in some patients and by the relative insensitivity of culturebased diagnosis [24].”
BackgroundSelf-citationGuitard, J., Tabone, M., Senghor, Y., Cros, C., Moissenet, D., Markowicz, K., Valin, N., Leverger, G., & Hennequin, C. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.07.007 · Cited by 35
“This poor prognosis is partly due to the weak performance of the currently available diagnostic instruments, highlighting the requirement for developing fungal biomarker tests.(2) Indeed, conventional diagnostic methods are both poorly sensitive and require a period of incubation, leading to a delay in initiating an a…”
Backgroundthe CAVA Trem Study Group, Parra-Sánchez, M., Breval, I. Z.-Y., Méndez, C. C., García-Rey, S., Vázquez, A. L., Úbeda, A., Guerrero, D. M., Mejías, A. R., Gil, C. L., et al. (2017) · Mycopathologia · doi:10.1007/s11046-017-0125-9 · Cited by 33
Jaiswal, A., Chakraborti, A., Verma, P., & Singhal, R. (2018) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_181_18 · Cited by 35
Direct Detection of Pathogens in Bloodstream During Sepsis: Are We There Yet?
Samuel, L. P. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.028274 · Cited by 39
“Invasive candidiasis continues to present a diagnostic challenge for laboratories, with BC being negative in 50% of proven and probable cases of invasive candidiasis (49, 50).”
BackgroundLuzzati, R., Cavinato, S., Deiana, M. L., Rosin, C., Maurel, C., & Borelli, M. (2014) · Aging Clinical and Experimental Research · doi:10.1007/s40520-014-0251-x · Cited by 33
Advances in the Diagnosis and Management of Invasive Fungal Disease
Formanek, P. E., & Dilling, D. F. (2019) · Chest · doi:10.1016/j.chest.2019.06.032 · Cited by 31
Molecular Diagnosis of Yeast Infections
White, P. L., Price, J. S., Cordey, A., & Backx, M. (2021) · Current Fungal Infection Reports · doi:10.1007/s12281-021-00421-x · Cited by 36
The SSS revolution in fungal diagnostics: speed, simplicity and sensitivity
Baker, J., & Denning, D. W. (2023) · British Medical Bulletin · doi:10.1093/bmb/ldad011 · Cited by 32
“Aside from mucosal candidiasis, life-threatening forms of Candida infections include candidaemia (bloodstream infection), tissue invasive candidiasis (deep-seated candidiasis) and peritoneal or intraabdominal candidiasis, which may occur concurrently or independently of candidaemia.(109) Usually these are grouped toge…”
BackgroundRecent Progress in the Diagnosis of Pathogenic Candida Species in Blood Culture
Phoompoung, P., & Chayakulkeeree, M. (2016) · Mycopathologia · doi:10.1007/s11046-016-0003-x · Cited by 31
“Unfortunately, the conventional blood culture technique for identifying Candida species has a low sensitivity (approximately 50 %) and is a time-consuming process for detecting candidemia [7, 8].”
BackgroundInvasive candidiasis: future directions in non-culture based diagnosis
Posch, W., Heimdörfer, D., Wilflingseder, D., & Lass‐Flörl, C. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1370373 · Cited by 31
“Sensitivity is low (42%) and depends on medical conditions; sensitivity was 30% in presence and 61% in absence of antifungal therapy [29,31].”
BackgroundFungal Infections in Burn Patients
Palackic, A., Popp, D., Tapking, C., Houschyar, K. S., & Branski, L. K. (2020) · Surgical Infections · doi:10.1089/sur.2020.299 · Cited by 33
“Similar to treating bacterial infections after resistance testing, there are new antifungal treatments available that are used specifically for particular strains [2,29–32].”
Rosario-Colon, J., EBERLE, K. E., Adams, A., Courville, E., & Xin, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116162 · Cited by 31
Evaluation of Droplet Digital PCR Assay for the Diagnosis of Candidemia in Blood Samples
Chen, B., Xie, Y., Zhang, N., Li, W., Liu, C., Li, D., Bian, S., Jiang, Y., Yang, Z., Li, R., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.700008 · Cited by 37
“However, this method has low sensitivity and requires large volumes of blood (Clancy and Nguyen, 2013; Pappas et al., 2018).”
MethodLin, S., Chen, R., Zhu, S., Wang, H., Wang, L., Zou, J., Yan, J., Zhang, X., Farmakiotis, D., Tan, X., et al. (2018) · Mycopathologia · doi:10.1007/s11046-018-0258-5 · Cited by 33
Pereira, F., & Rammaert, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00230-5 · Cited by 30
George, M. E., Gaitor, T. T., Cluck, D. B., Henao‐Martínez, A. F., Sells, N. R., & Chastain, D. B. (2025) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361251313841 · Cited by 71
Bruyère, R., Quenot, J., Prin, S., Dalle, F., Vigneron, C., Aho, S., León, C., & Charles, P. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-385 · Cited by 37
“Taken together, our findings suggest that IC could remain hidden in a subgroup of high-risk critically-ill patients, thus illustrating the acknowledged lack of sensitivity of the currently available diagnosis tool, blood culture, in the “medical” setting [25].”
BackgroundPediatric Invasive Candidiasis: Epidemiology and Diagnosis in Children
Steinbach, W. J. (2016) · Journal of Fungi · doi:10.3390/jof2010005 · Cited by 38
“While the sensitivity of blood cultures for candidemia ranges between 63% and 83% [43,44], and likely even worse in children due to lower blood volumes used, the mean time to positivity for Candida spp.”
BackgroundUse of (1→3)‐β‐ d ‐glucan for diagnosis and management of invasive mycoses in HIV ‐infected patients
Farhour, Z., Mehraj, V., Chen, J., Ramendra, R., Lu, H., & Routy, J. (2018) · Mycoses · doi:10.1111/myc.12797 · Cited by 33
“They were able to show that the level of plasma BDG correlated with soluble CD14 (sCD14), marker of monocyte activation and lower proportions of gut Lactobacilli in PLHIV not having IFIs.32,33 Furthermore, elevated levels of plasma BDG was recently reported as a potential marker contributing to systemic immune activat…”
BackgroundInfluentialAgnelli, C., Bouza, E., Martínez‐Jiménez, M. D. C., Navarro, R., Valerio, M., Machado, M., Guinea, J., Sánchez‐Carrillo, C., Alonso, R., & Muñóz, P. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz555 · Cited by 29
Kritikos, A., Poissy, J., Croxatto, A., Bochud, P., Pagani, J., & Lamoth, F. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01996-19 · Cited by 29
“The BDG test may detect the missed cases and allow early start of AF therapy and clearance of the pathogen before cultures turn positive (24).”
BackgroundDiagnosis from Tissue: Histology and Identification
Sabino, R., & Wiederhold, N. P. (2022) · Journal of Fungi · doi:10.3390/jof8050505 · Cited by 35
“The sensitivity of yeast cultures from the bloodstream has been reported to range between 21–71% due to the rapid clearance of viable organisms, leading to a relatively low number of colony-forming units per milliliter of blood [10,11].”
BackgroundDevelopment of a Lateral Flow Immunoassay for the Rapid Diagnosis of Invasive Candidiasis
He, Z., Shi, L.-C., Ran, X., Li, W., Wang, X., & Wang, F. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01451 · Cited by 32
“Frontiers in Microbiology | www.frontiersin.org 4 September 2016 | Volume 7 | Article 1451 FIGURE 2 | ELISA test results for the study subjects.”
BackgroundInfluentialGarcía‐Effrón, G. (2021) · Journal of Fungi · doi:10.3390/jof7030197 · Cited by 31
Steinbrink, J. M., Myers, R. A., Hua, K., Johnson, M. D., Seidelman, J., Tsalik, E. L., Henao, R., Ginsburg, G. S., Woods, C. W., Alexander, B. D., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00924-9 · Cited by 30
“Discussion Multiple pathogen-based diagnostic modalities for candidemia are currently available but often hindered by delayed time-to-result and/or suboptimal sensitivity and specificity [11, 12, 14, 15].”
BackgroundInvasive fungal infections in liver diseases
Barros, N., Rosenblatt, R. E., Phipps, M. M., Fomin, V. G., & Mansour, M. K. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000216 · Cited by 35
“[62] The sensitivity of blood cultures with automated blood culture systems for bloodstream infections with or without deep-seated infections can reach up to 75%.[62] However, the sensitivity is much lower in cases of intermittent candidemia and deepseated candidiasis without candidemia.”
BackgroundMethodBerg, T., Aehling, N., Bruns, T., Welker, M., Weismüller, T. J., Trebicka, J., Tacke, F., Strnad, P., Sterneck, M. R., Settmacher, U., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2255-7246 · Cited by 32
Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia
Eschenauer, G. A., Nguyen, M.-H., & Clancy, C. J. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015590838 · Cited by 27
Self-citationPini, P., Bettua, C., Orsi, C. F., Venturelli, C., Forghieri, F., Bigliardi, S., Faglioni, L., Luppi, F., Serio, L., Codeluppi, M., et al. (2015) · Infection · doi:10.1007/s15010-015-0849-8 · Cited by 31
“As far as ICU patients, the literature provides once again heterogeneous results, probably because of substantial differences in study design and investigated populations; also, intrinsic limitations, such as blood culture analysis that still remains the gold standard for IC classification [17, 30], may partially cont…”
BackgroundThe burden of fungal disease in Denmark
Mortensen, K. L., Denning, D. W., & Arendrup, M. C. (2015) · Mycoses · doi:10.1111/myc.12383 · Cited by 27
Baker, A. D., Gold, J. A. W., Forsberg, K., Jones, S., & Lyman, M. M. (2025) · Emerging Infectious Diseases · doi:10.3201/eid3108.250315 · Cited by 27
“StC events could have been missed be - cause of missed screening opportunities, the insensitivity of culture ( 9 ), treating clinical laboratories that might not routinely distinguish C. auris from other Candida species for nonsterile specimen types ( 10 ), and the fact that US C. auris data from…”
Wang, K., Luo, Y., Zhang, W., Xie, S., Yan, P., Liu, Y., Li, Y., Ma, X., Xiao, K., Fu, H., et al. (2019) · Mycoses · doi:10.1111/myc.13035 · Cited by 33
Rapid Detection of Echinocandins Resistance by MALDI-TOF MS in Candida parapsilosis Complex
Roberto, A. E. M., Xavier, D. E., Vidal, E. E., Vidal, C. F. D. L., Neves, R. P., & de Lima-Neto, R. G. (2020) · Microorganisms · doi:10.3390/microorganisms8010109 · Cited by 30
“Invasive candidiasis presents unspecific clinical symptoms, which make early diagnosis difficult, requiring blood cultures that are time-consuming and have little sensitivity [6].”
BackgroundVaz, C., Pitarch, A., Gómez-Molero, E., Amador-García, A., Weig, M., Bader, O., Monteoliva, L., & Gil, C. (2021) · Journal of Fungi · doi:10.3390/jof7070501 · Cited by 29
“However, blood cultures can take 2-5 days to attain a decisive result and are not useful for the diagnosis of deep-seated candidiasis in the absence of candidemia; in contrast histopathological examination is often a too invasive method for critically ill patients [7, 12].”
MethodPiqueras, A., Ganapathi, L., Carpenter, J. F., Rubio, T. T., Sandora, T. J., Flett, K. B., & Köhler, J. R. (2021) · Journal of Fungi · doi:10.3390/jof7020078 · Cited by 31
Diagnosis, Prevention, and Treatment of Infections in Kidney Transplantation
Bharati, J., Anandh, U., Kotton, C. N., Mueller, T., Shingada, A., & Ramachandran, R. (2023) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2023.151486 · Cited by 29
Shabaan, A. E., Elbaz, L. M., Elemshaty, W., & Shouman, B. (2017) · Jornal de Pediatria · doi:10.1016/j.jped.2017.07.020 · Cited by 27
Govender, N. P., Avenant, T., Brink, A. J., Chibabhai, V., Cleghorn, J., du Toit, B., Govind, C., Lewis, E., Lowman, W., Mahlangu, H., et al. (2019) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v34i1.163 · Cited by 46
Camp, I., Manhart, G., Schabereiter‐Gurtner, C., Spettel, K., Selitsch, B., & Willinger, B. (2020) · Infection · doi:10.1007/s15010-020-01395-7 · Cited by 27
Chen, P., Wu, H., Zhao, Y., Zhong, L., Zhang, Y., Zhan, X., Xiao, A., Huang, Y., Zhang, H., & Guan, B. (2024) · Advanced Materials · doi:10.1002/adma.202312985 · Cited by 30
Fisher, B. T., Boge, C. L. K., Xiao, R., Shuster, S., Chin‐Quee, D. S., Allen, J. E., Shaheen, S. K., Hayden, R. T., Suganda, S., Zaoutis, T. E., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab928 · Cited by 26
Profile of GenMark’s ePlex® blood culture identification fungal pathogen panel
Maubon, D., Dard, C., Garnaud, C., & Cornet, M. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1420476 · Cited by 23
“For comparison, considering Candida, 1 CFU/mL of blood is the median concentration needed to turn a blood culture positive [63,64], explaining why the BCID-FP panel has to be used on blood-culture samples after incubation and once positivity has been detected by automated systems, and not directly on blood samples.”
MethodWei, S., Wu, T. H., Wu, Y., Ding, M., & Zhu, X. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.017 · Cited by 25
T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit
Gill, C. M., Kenney, R. M., Hencken, L. N., Mlynarek, M. E., Alangaden, G. J., Samuel, L. P., & Davis, S. L. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.04.016 · Cited by 24
Liotti, F. M., Posteraro, B., Mannu, F., Carta, F., Pantaleo, A., Angelis, G. D., Menchinelli, G., Spanu, T., Fiori, P. L., Turrini, F. M., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00389 · Cited by 28
“The microbial density in blood is generally very low, particularly for cases of invasive candidiasis that encompass candidemia and deep-seated candidiasis (Clancy and Nguyen, 2013).”
Background
Metadata
- Authors
- Clancy, C. J., & Nguyen, M. H.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Clancy, Cornelius J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-11
- Volume
- 56
- Issue
- 9
- Pages
- 1284-1292
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2113002556
- Semantic Scholar
- 09ab621e4fddac8144b07f459f06bc7901d0d1bd
- Cited by
- 688
- References
- 39
- Citations by year
- 2026: 36 · 2025: 56 · 2024: 55 · 2023: 60 · 2022: 59 · 2021: 68 · 2020: 56 · 2019: 66 · 2018: 60 · 2017: 54 · 2016: 52 · 2015: 32 · 2014: 26 · 2013: 8
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- invasive candidiasis, beta-D-glucan assay, sensitivity and specificity, positive predictive value, negative predictive value, antifungal therapy, disease spectrum, biomarkers
- MeSH terms
- DNA, Fungal, Patient Care, Humans, Predictive Value of Tests, Sensitivity and Specificity, Biomarkers, Clinical Laboratory Techniques, beta-Glucans, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.